Serum Peptide Identification - Serum Peptide Identification with no fractionation
Ontology highlight
ABSTRACT:
INSTRUMENT(S): Q-Tof Premier, instrument model
ORGANISM(S): Homo Sapiens (human)
DISEASE(S): Thanatophoric Dysplasia,Malignant Neoplasm Of Ovary
SUBMITTER: 
ALI TISS
PROVIDER: PRD000200 | Pride | 2010-06-30
REPOSITORIES: Pride
Dataset's files
Items per page: 5 1 - 5 of 6 |
Similar Datasets
Project description:Identification of Human serum peptides Using ESI-QTOF
2010-07-30 | PRD000203 | Pride
Project description:Lignocellulose fractionation by microbial consortia
| PRJEB26853 | ENA
Project description:Albuminome from human serum was isolated using ProteaPrep HSA affinity spin columns and Vivapure anti-HSA spin columns. Albuminome from CSF was isolated using ProteaPrep HSA affinity spin columns. Isolated albuminome was trypsin digested and analyzed by LC-MS/MS to determine serum and CSF albuminome proteins. All raw MS/MS data originating from the Orbitrap Elite were batch searched based on albuminome isolation method (ProteaPrep vs. Vivapure). A total of 9 files were acquired for each albuminome analyzed (3 technical reps x 3 MS technical reps). All data were searched using the Sorcerer 2TM-SEQUEST algorithm (Sage-N Research, Milpitas, CA, USA) using default peak extraction parameters. Data were searched against the Human Uniprot database (July 2012) with an Xcorr cutoff of 1.7 using the following criteria: Fixed modification: +57 on C (carbamidomethyl); Variable modification: +16 on M (oxidation); Enzyme: Trypsin with 2 max missed cleavages; Parent Tolerance: 50 ppm; Fragment tolerance: 1.00 Da. Post-search analysis was performed using Scaffold 3 version 3.6.2 (Proteome Software, Inc., Portland, OR, USA) with protein and peptide probability thresholds set to 95% and 90%, respectively, and one peptide required for identification. Protein and peptide false discovery rates were calculated automatically using Scaffold’s probabilistic method and were equal to or less than 0.5 % for all samples using the above thresholds. Data were imported in Protein Center (Proxeon/ThermoFisher) and all data were clustered by indistinguishable proteins to remove protein redundancy within data sets. Only proteins that were observed in all three technical replicates were included in the final protein list, although proteins observed it at least two technical replicates were included in the on-line supplement for reference.
2013-02-25 | PXD000036 | Pride
Project description:Circulating antibodies provide valuable information about an individual’s immune status and constitute a significant portion of the human plasma proteome. Proteomic analysis of plasma is challenged by the large dynamic concentration range of plasma proteins, including antibodies. Peptide fractionation prior to data-independent (shotgun) proteomics has the potential to overcome this obstacle and enable increased coverage of plasma proteins. In this work, we evaluated the detection of tryptic immunoglobulin variable region peptides using multidimensional chromatography (high-pH preparative LC) or gas-phase ion mobility spectrometry (FAIMS). Typical digests of eight serum samples were obtained by (a) direct LC-MS (without prior fractionation, 1D), (b) LC-FAIMS-MS, and (c) high-pH reversed-phase fractionation into 24 fractions and subsequent measurement of each fraction. As de novo search is an essential step in antibody variable region peptide identification, all MS/MS spectra were acquired in high resolution Orbitrap mode.
2024-08-09 | PXD046072 | Pride
Project description:Primary Open-Angle Glaucoma (POAG) and Pseudoexfoliation Glaucoma (PEXG) are forms of glaucoma with distinct etiologies, but they share a common type of optic neurodegeneration that leads to irreversible loss of retinal ganglion cells, visual field and blindness if left untreated. The main objective in the present study was to explore whether differential-proteomic analysis of blood serum from patients with POAG or PEXG could lead to the identification of candidate biomarkers of glaucoma and provide clues to pathogenic mechanisms. A total of 202 blood samples from medically treated patients with POAG (n=73), PEXG (n=59), and cataracts (control, n=70) were collected and analyzed following a proteomic workflow that involved two phases: discovery and validation. In the discovery phase, differential-proteomics (2D-DIGE) methodology led to the identification of a panel of 35 proteins that were altered (i.e., over- or under-expressed) in serum samples of glaucoma patients. Functional pathway analysis suggested a potential involvement of these proteins in immunological and inflammatory pathways. In the validation phase, ELISA assays of the top-17-ranked proteins confirmed that most of them were over-expressed in the glaucoma groups. Stepwise discriminant analysis of the ELISA data resulted in a six-protein panel (APOA4, TF, C3, APOL1, IGHG2, C4A) that was used to generate multivariate predictive models. These models achieved a diagnostic efficiency of 81% (correct assignment), specificity of 83%, and sensitivity of 92%. Specifically, 100% efficacy was reached in the discrimination of the POAG group from control, and 86% efficacy in the discrimination of POAG from PEXG. Overall, these data demonstrate the discovery of a panel of serum biomarkers that could be used in large-scale multiplexed screenings for the diagnosis of POAG and PEXG patients. Furthermore, these biomarkers may have a role in the pathogenesis, and association to immune-inflammatory processes with glaucoma.
2014-01-17 | PXD000198 | Pride
Project description:The affinity purification/MS identification methodology reported here can be viewed as a routine pharmacoproteomic approach to investigate the serum interactome of peptide drugs, identifying proteins affecting bioavailability and thus assisting the peptide drug development process. The specific results described here enlighten the serum stability issues of peptide Ctn[15-34] and ratifiy its promising future as an anti-infective lead.
2019-05-06 | PXD013425 | Pride
Project description:Experimental design For the label-free proteome analysis 17 mice were used composed of 5 individual wildtype mice for each condition before (WTprePHE) and after hepatectomy (WTpostPHE). For the pre-hepatectomy condition four BIRC5-knockout mice (KOprePHE) were analyzed and three individuals after partial hepatectomy (KOpostPHE). For the LC-MS/MS analysis the samples were pre-fractionated by subcellular protein fractionatio. All samples corresponding to a subcellular fraction were analyzed in an individual label-free study. Subcellular protein fractionation The subcellular fractions were generated using the Subcellular Protein Fractionation Kit for Tissue (Thermo Scientific, Bremen, Germany). Sample preparation and tryptic digestion 5ug of protein were loaded on a 18% Tris-glycine acrylamide gel (Anamed Electrophorese, Grosz-Bieberau, Germany). The samples were allowed to run slightly into the gel (15 min, 100 V) and form a single band of approximately 3mm height. The bands were stained with Coomassie, manually cut from the gel and digested with trypsin (Serva Electrophoresis, Heidelberg, Germany) in 10 mM ammonium bicarbonate buffer (pH 7.8) overnight at 37 degrees C. LC-MS/MS Analysis The RPLC-MS/MS analysis was performed using an Ultimate 3000 RSLCnano system (Thermo Scientific, Bremen, Germany) online coupled to an Orbitrap Elite mass spectrometer (Thermo Scientific, Bremen, Germany). The injection volume was 15 ul of the sample, representing an amount of 250 ng peptides.The MS was operated in a data-dependent mode. Full scan MS spectra were acquired at a resolution of 60,000 in the Orbitrap analyzer, while tandem mass spectra of the twenty most abundant peaks were measured in the linear ion trap after peptide fragmentation by collision-induced dissociation (CID).
2014-05-22 | PXD000625 | Pride
Project description:Efficient cellular fractionation of RNA
| PRJEB4845 | ENA
Project description:We evaluated the utility of a trimodal stationary phase (Trinity P1) in offline peptide fractionation, and found it performed similarly to ion exchange or high pH reversed phase based techniques. It is orthogonal to low pH reversed phase and uses MS compatible mobile phase solvents.
2017-08-07 | PXD006188 | Pride